Annual report pursuant to Section 13 and 15(d)

Fair Value Measurements (Tables)

v3.20.4
Fair Value Measurements (Tables)
12 Months Ended
Dec. 31, 2020
Fair Value Disclosures [Abstract]  
Summary of Financial Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following table summarizes the Company's financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2020:
(in millions) Level 1 Level 2 Total
Assets:      
Cash equivalents $ 19.3  $ —  $ 19.3 
Short-term investments in marketable securities 56.7  —  56.7 
Restricted cash 10.7  —  10.7 
Derivatives —  2.2  2.2 
Total assets $ 86.7  $ 2.2  $ 88.9 
Liabilities:      
Derivatives $ —  $ 12.0  $ 12.0 
Deferred compensation 1.1  18.7  19.8 
Total liabilities at fair value $ 1.1  $ 30.7  $ 31.8 
Liabilities measured at net asset value 10.7 
Total liabilities $ 42.5 

The following table summarizes the Company's financial assets and liabilities measured at fair value on a recurring basis as of December 31, 2019:
(in millions) Level 1 Level 2 Total
Assets:      
Cash equivalents $ 0.3  $ —  $ 0.3 
Short-term investments in marketable securities 0.8  —  0.8 
Restricted cash 11.6  —  11.6 
Derivatives —  4.2  4.2 
Total assets $ 12.7  $ 4.2  $ 16.9 
Liabilities:      
Derivatives $ —  $ 3.2  $ 3.2 
Deferred compensation 1.2  18.8  20.0 
Total liabilities at fair value $ 1.2  $ 22.0  $ 23.2 
Liabilities measured at net asset value 8.5 
Total liabilities $ 31.7 

Refer to Note 14 – Financial Instruments for additional information related to the fair value of derivative assets and liabilities by class. In addition to the items shown in the tables above, see Note 17 – Postretirement Benefits for further discussion regarding the fair value measurements associated with the Company's postretirement benefit plans.